Botox injections may help stroke survivors move their arms better
NCT ID NCT03783572
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study observed 18 chronic stroke patients who received botulinum toxin injections into their elbow muscles as part of routine care. The goal was to see if the injections reduced muscle tightness (spasticity) and improved active arm extension. Researchers measured muscle activity and spasticity before and after treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
18 people
The number who actually took part.
- Started
-
Dec 2020
- Finished
-
Jun 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Stroke group : Inclusion Criteria: * Cortical and/or subcortical ischemic or haemorrhagic stroke for at least 6 months; * Indication to an injection of BTA in the elbow flexor muscles according to the usual clinical criteria: request of elbow extension improvement with a functional or aesthetic objective; * Being under prescription of abobotulinum toxin A (DYSPORT®, Ipsen-Pharma); * Ability of active elbow extension\> 20 degrees; * Limitation of active movement of elbow extension \> 15 degrees or decreased or 50% decrease in the active elbow extension rate; * Patients who have never been treated with BTX or only a first injection that having targeted the elbow flexors more than 4 months ago; * Age\> 18 years; * Signature of informed consent; * Subject affiliated to the social security coverture. Exclusion Criteria: * Passive limitation of elbow extension \> 30 degrees; * Pain during active movements of elbow flexion/extension; * Cognitive disorder with limited comprehension of three basic instructions (like the test of the 3 papers of the MMS); * Evolutionary or decompensated neurological disease; * Unstabilized epilepsy; * Anticoagulant treatment with a curative dose or hemostasis disorder that contraindicates intramuscular injections; * Claustrophobia or metallic foreign bodies contraindicated for MRI; * General contraindication for botulinum toxin injection: hypersensitivity to the active substance or to one of the excipients, swallowing disorder, chronic respiratory disorders, antecedent of myasthenia or Lambert Eaton syndrome; antecedent of neuromuscular disease; surgery with curarization for less than a month; current treatment with aminoglycoside, aminoquinoline, cyclosporine or anticholinesterase. * Presence of skin infection or inflammation at the injection site. * Legal incapacity. * Pregnant or breastfeeding woman; * Woman with a desire to become pregnant within 18 months. * Non-menopausal woman (a postmenopausal state is defined as no menses for 12 months without an alternative medical cause) who does not use one of the following contraceptive methods considered highly effective : intrauterine device, oestroprogestonic contraception or progestogen hormonal contraception associated with inhibition of ovulation, intrauterine hormone-releasing system, or bilateral tubal occlusion. Control group * inclusion criteria: * Age\> 18 years * Signature of informed consent. * exclusion criteria: * History of orthopedic or neurologic disorders; * Subject expert in a sport intensively requiring the upper limbs (at least departmental competition level); * Legal incapacity.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Muscle spasticity are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Toulouse
Toulouse, 31059, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Muscle disease may confuse heart attack tests: study aims to clarify
- Robot could let stroke patients rehab their hands at home without a therapist
- Moving patterns may help stroke survivors read faster
- Vibrating wearables put stroke walking to the test
- Robot plus electrical stimulation aims to rebuild arm movement after stroke
- Can a checklist and heart monitor stop repeat strokes?